Plasma Proteomics and Metabolomics of Aromatase Inhibitors-Related Musculoskeletal Syndrome in Early Breast Cancer Patients
This study offered new insights into the mechanisms underlying musculoskeletal symptoms associated with aromatase inhibitors. It also highlighted potential biomarkers for predicting and addressing these symptoms in breast cancer patients, paving the way for improved intervention strategies.
Authors
- Jiajia Qiu (ORCID: https://orcid.org/0000-0003-4212-3159)
- Feng Jing (ORCID: https://orcid.org/0000-0002-6591-9638)
- Yuling Cao
- Yan Hu (ORCID: https://orcid.org/0000-0001-6506-0694)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-8449-6554)
- Lingyun Jiang
- Maoting Tian (ORCID: https://orcid.org/0000-0002-5808-6877)
- Renquan Lu
- Lichen Tang
Institutions
- Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
Publication Details
- Journal
- Metabolites
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3390/metabo15030153
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China